Human Milk Oligosaccharides Modulate the Risk for Preterm Birth in a Microbiome-Dependent and -Independent Manner

ABSTRACT Preterm birth (PTB) is one of the leading causes of neonatal mortality. The causes for spontaneous PTB are multifactorial and often remain unknown. In this study, we tested the hypothesis that human milk oligosaccharides (HMOs) in blood and urine modulate the maternal urinary and vaginal mi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Manuela-Raluca Pausan, Vassiliki Kolovetsiou-Kreiner, Gesa Lucia Richter, Tobias Madl, Elisabeth Giselbrecht, Barbara Obermayer-Pietsch, Eva-Christine Weiss, Evelyn Jantscher-Krenn, Christine Moissl-Eichinger
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://doaj.org/article/ce1160942cce4df1847ce02c6c86ac50
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ce1160942cce4df1847ce02c6c86ac50
record_format dspace
spelling oai:doaj.org-article:ce1160942cce4df1847ce02c6c86ac502021-12-02T18:23:16ZHuman Milk Oligosaccharides Modulate the Risk for Preterm Birth in a Microbiome-Dependent and -Independent Manner10.1128/mSystems.00334-202379-5077https://doaj.org/article/ce1160942cce4df1847ce02c6c86ac502020-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSystems.00334-20https://doaj.org/toc/2379-5077ABSTRACT Preterm birth (PTB) is one of the leading causes of neonatal mortality. The causes for spontaneous PTB are multifactorial and often remain unknown. In this study, we tested the hypothesis that human milk oligosaccharides (HMOs) in blood and urine modulate the maternal urinary and vaginal microbiome and influence the risk for PTB. We analyzed the vaginal and urinary microbiome of a cross-sectional cohort of women with or without preterm labor and correlated our findings with measurements of metabolites and HMOs in urine and blood. We identified several microbial signatures, such as Lactobacillus jensenii, L. gasseri, Ureaplasma sp., and Gardnerella sp., associated with a short cervix, PTB, and/or preterm contractions. In addition, we observed associations between sialylated HMOs, in particular 3′-sialyllactose, with PTB, short cervix, and increased inflammation and confirmed an influence of HMOs on the microbiome profile. Since they identify serum and urinary HMOs and several key microorganisms associated with PTB, our findings point at two distinct processes modulating the risk for PTB. One process seems to be driven by sterile inflammation, characterized by increased concentrations of sialylated HMOs in serum. Another process might be microbiome mediated and potentially associated with specific HMO signatures in urine. Our results support current efforts to improve diagnostics and therapeutic strategies in PTB. IMPORTANCE The causes for preterm birth (PTB) often remain elusive. We investigated whether circulating human milk oligosaccharides (HMOs) might be involved in modulating urinary and vaginal microbiome promoting or preventing PTB. We identified here HMOs and key microbial taxa associated with indicators of PTB. Based on our results, we propose two models for how HMOs might modulate risk for PTB: (i) by changes in HMOs associated with sterile inflammation (microbiome-independent) and (ii) by HMO-driven shifts in microbiome (microbiome-dependent). Our findings will guide current efforts to better predict the risk for PTB in seemingly healthy pregnant women and also provide appropriate preventive strategies.Manuela-Raluca PausanVassiliki Kolovetsiou-KreinerGesa Lucia RichterTobias MadlElisabeth GiselbrechtBarbara Obermayer-PietschEva-Christine WeissEvelyn Jantscher-KrennChristine Moissl-EichingerAmerican Society for Microbiologyarticlepregnancypreterm deliveryvaginal and urinary microbiomehuman milk oligosaccharidesinflammationsecretor statusMicrobiologyQR1-502ENmSystems, Vol 5, Iss 3 (2020)
institution DOAJ
collection DOAJ
language EN
topic pregnancy
preterm delivery
vaginal and urinary microbiome
human milk oligosaccharides
inflammation
secretor status
Microbiology
QR1-502
spellingShingle pregnancy
preterm delivery
vaginal and urinary microbiome
human milk oligosaccharides
inflammation
secretor status
Microbiology
QR1-502
Manuela-Raluca Pausan
Vassiliki Kolovetsiou-Kreiner
Gesa Lucia Richter
Tobias Madl
Elisabeth Giselbrecht
Barbara Obermayer-Pietsch
Eva-Christine Weiss
Evelyn Jantscher-Krenn
Christine Moissl-Eichinger
Human Milk Oligosaccharides Modulate the Risk for Preterm Birth in a Microbiome-Dependent and -Independent Manner
description ABSTRACT Preterm birth (PTB) is one of the leading causes of neonatal mortality. The causes for spontaneous PTB are multifactorial and often remain unknown. In this study, we tested the hypothesis that human milk oligosaccharides (HMOs) in blood and urine modulate the maternal urinary and vaginal microbiome and influence the risk for PTB. We analyzed the vaginal and urinary microbiome of a cross-sectional cohort of women with or without preterm labor and correlated our findings with measurements of metabolites and HMOs in urine and blood. We identified several microbial signatures, such as Lactobacillus jensenii, L. gasseri, Ureaplasma sp., and Gardnerella sp., associated with a short cervix, PTB, and/or preterm contractions. In addition, we observed associations between sialylated HMOs, in particular 3′-sialyllactose, with PTB, short cervix, and increased inflammation and confirmed an influence of HMOs on the microbiome profile. Since they identify serum and urinary HMOs and several key microorganisms associated with PTB, our findings point at two distinct processes modulating the risk for PTB. One process seems to be driven by sterile inflammation, characterized by increased concentrations of sialylated HMOs in serum. Another process might be microbiome mediated and potentially associated with specific HMO signatures in urine. Our results support current efforts to improve diagnostics and therapeutic strategies in PTB. IMPORTANCE The causes for preterm birth (PTB) often remain elusive. We investigated whether circulating human milk oligosaccharides (HMOs) might be involved in modulating urinary and vaginal microbiome promoting or preventing PTB. We identified here HMOs and key microbial taxa associated with indicators of PTB. Based on our results, we propose two models for how HMOs might modulate risk for PTB: (i) by changes in HMOs associated with sterile inflammation (microbiome-independent) and (ii) by HMO-driven shifts in microbiome (microbiome-dependent). Our findings will guide current efforts to better predict the risk for PTB in seemingly healthy pregnant women and also provide appropriate preventive strategies.
format article
author Manuela-Raluca Pausan
Vassiliki Kolovetsiou-Kreiner
Gesa Lucia Richter
Tobias Madl
Elisabeth Giselbrecht
Barbara Obermayer-Pietsch
Eva-Christine Weiss
Evelyn Jantscher-Krenn
Christine Moissl-Eichinger
author_facet Manuela-Raluca Pausan
Vassiliki Kolovetsiou-Kreiner
Gesa Lucia Richter
Tobias Madl
Elisabeth Giselbrecht
Barbara Obermayer-Pietsch
Eva-Christine Weiss
Evelyn Jantscher-Krenn
Christine Moissl-Eichinger
author_sort Manuela-Raluca Pausan
title Human Milk Oligosaccharides Modulate the Risk for Preterm Birth in a Microbiome-Dependent and -Independent Manner
title_short Human Milk Oligosaccharides Modulate the Risk for Preterm Birth in a Microbiome-Dependent and -Independent Manner
title_full Human Milk Oligosaccharides Modulate the Risk for Preterm Birth in a Microbiome-Dependent and -Independent Manner
title_fullStr Human Milk Oligosaccharides Modulate the Risk for Preterm Birth in a Microbiome-Dependent and -Independent Manner
title_full_unstemmed Human Milk Oligosaccharides Modulate the Risk for Preterm Birth in a Microbiome-Dependent and -Independent Manner
title_sort human milk oligosaccharides modulate the risk for preterm birth in a microbiome-dependent and -independent manner
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/ce1160942cce4df1847ce02c6c86ac50
work_keys_str_mv AT manuelaralucapausan humanmilkoligosaccharidesmodulatetheriskforpretermbirthinamicrobiomedependentandindependentmanner
AT vassilikikolovetsioukreiner humanmilkoligosaccharidesmodulatetheriskforpretermbirthinamicrobiomedependentandindependentmanner
AT gesaluciarichter humanmilkoligosaccharidesmodulatetheriskforpretermbirthinamicrobiomedependentandindependentmanner
AT tobiasmadl humanmilkoligosaccharidesmodulatetheriskforpretermbirthinamicrobiomedependentandindependentmanner
AT elisabethgiselbrecht humanmilkoligosaccharidesmodulatetheriskforpretermbirthinamicrobiomedependentandindependentmanner
AT barbaraobermayerpietsch humanmilkoligosaccharidesmodulatetheriskforpretermbirthinamicrobiomedependentandindependentmanner
AT evachristineweiss humanmilkoligosaccharidesmodulatetheriskforpretermbirthinamicrobiomedependentandindependentmanner
AT evelynjantscherkrenn humanmilkoligosaccharidesmodulatetheriskforpretermbirthinamicrobiomedependentandindependentmanner
AT christinemoissleichinger humanmilkoligosaccharidesmodulatetheriskforpretermbirthinamicrobiomedependentandindependentmanner
_version_ 1718378124646809600